Exact Mass: 357.02019420000005
Exact Mass Matches: 357.02019420000005
Found 108 metabolites which its exact mass value is equals to given mass value 357.02019420000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
TOLRESTAT
C16H14F3NO3S (357.06464500000004)
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10X - Other drugs used in diabetes > A10XA - Aldose reductase inhibitors C471 - Enzyme Inhibitor > C72880 - Aldose Reductase Inhibitor D004791 - Enzyme Inhibitors
Chlorsulfuron
C12H12ClN5O4S (357.02985020000006)
D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals
Cinolazepam
Cinolazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Cinolazepam is not approved for sale in the United States or Canada.Cinolazepam binds to central benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways. N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
2,4-Dihydroxy-1,4-benzoxazin-3-one glucuronide
Droxicam
C16H11N3O5S (357.04193960000003)
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AC - Oxicams C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Florfenicol
C12H14Cl2FNO4S (357.00045960000006)
2,2-dichloro-N-[3-fluoro-1-hydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamide
C12H14Cl2FNO4S (357.00045960000006)
N1-(4-Chlorophenyl)-2-{amino[5-(trifluoromethyl)-2-pyridyl]methylidene}hydrazine-1-carboxamide
PRP_M358a
C15H17Cl2N3O3 (357.0646912000001)
CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2401
1,1-S-Dioxide-3,3-(1-Methyl-2,5-pyrrolidinediyl)bis-1,2-dithiolan-4-ol
Aristolochic acid Va
aristolochic D
Aristolochic acid D is an aristolochic acid that is phenanthrene-1-carboxylic acid substituted by a methylenedioxy group at the 3,4 positions, by an hydroxy group at position 6, by a methoxy group at position 8, and by a nitro group at position 10. It has a role as a carcinogenic agent, a metabolite, a nephrotoxin and a toxin. It is a C-nitro compound, a member of aristolochic acids, an aromatic ether, a cyclic acetal, a monocarboxylic acid and an organic heterotetracyclic compound. Aristolochic acid d is a natural product found in Aristolochia kaempferi, Aristolochia mollissima, and Aristolochia heterophylla with data available. An aristolochic acid that is phenanthrene-1-carboxylic acid substituted by a methylenedioxy group at the 3,4 positions, by an hydroxy group at position 6, by a methoxy group at position 8, and by a nitro group at position 10.
7-Hydroxyaristolochate A
Florfenicol
C12H14Cl2FNO4S (357.00045960000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic C784 - Protein Synthesis Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 3641
PRP_M358b
C15H17Cl2N3O3 (357.0646912000001)
CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2402
Cinolazepam
N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
4-(5-Bromopyrimidin-2-yloxy)piperidine-1-carboxylic acid tert-butyl
6-BROMO-2-(3-METHOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
C17H12BrNO3 (357.00005020000003)
2-ethoxy-5-[(4-fluorobenzoyl)amino]benzenesulfonyl chloride
C15H13ClFNO4S (357.0237820000001)
2-N-BOC-2-AMINOMETHYL-3-(4-BROMO-PHENYL)-PROPIONIC ACID
C15H20BrNO4 (357.0575620000001)
6-BROMO-2-(4-METHOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
C17H12BrNO3 (357.00005020000003)
(+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride
(2S)-3-amino-4-(3-bromophenyl)-2-[(2-methylpropan-2-yl)oxycarbonyl]butanoic acid
C15H20BrNO4 (357.0575620000001)
2-N-BOC-2-AMINOMETHYL-3-(3-BROMO-PHENYL)-PROPIONIC ACID
C15H20BrNO4 (357.0575620000001)
2-(4-BROMO-PHENYL)-6-METHOXY-QUINOLINE-4-CARBOXYLIC ACID
C17H12BrNO3 (357.00005020000003)
ETHYL 6-IODO-8-METHYL-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLATE
Potassium 1-Boc-6-chloroindole-2-trifluoroborate
C13H13BClF3KNO2 (357.03169940000004)
1,5-bis-(4-chlorophenyl)-biguanide hcl
C14H14Cl3N5 (357.03147340000004)
2,2,2-Trifluoro-1-(4-methylphenyl)-O-[(4-methylphenyl)sulfonyl]oxime ethanone
C16H14F3NO3S (357.06464500000004)
n-(2-bromophenyl)-n-methyl-3-(trifluoromethyl)benzamide
(R)-6-Benzyloxymethyl-4-methyl-5,6-dihydro-pyran-2-one
Boc-(S)-3-amino-4-(4-bromophenyl)-butyric acid
C15H20BrNO4 (357.0575620000001)
3-CHLORO-1-(2-TRIFLUOROMETHYL-PHENOTHIAZIN-10-YL)-PROPAN-1-ONE
C16H11ClF3NOS (357.02019420000005)
2-BROMO-4-(3,6,6-TRIMETHYL-4-OXO-4,5,6,7-TETRAHYDRO-1H-INDAZOL-1-YL)BENZONITRILE
Ethyl 6-bromo-4-chloro-7-ethoxyquinoline-3-carboxylate
C14H13BrClNO3 (356.97672780000005)
Midaflur
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic
boc-(r)-3-amino-4-(2-bromo-phenyl)-butyric acid
C15H20BrNO4 (357.0575620000001)
Boc-(S)-3-Amino-4-(2-bromo-phenyl)-butyric acid
C15H20BrNO4 (357.0575620000001)
BOC-(R)-3-amino-4-(4-bromo-phenyl)-butyric acid
C15H20BrNO4 (357.0575620000001)
methyl (2S)-(tert-butoxycarbonylamino)-5-iodopentanoate
C11H20INO4 (357.04370300000005)
1,3,5-Triazine,2-chloro-4-(1-dibenzofuranyl)-6-phenyl-
C21H12ClN3O (357.06688520000006)
2-Chloro-4-(4-dibenzofuranyl)-6-phenyl-1,3,5-triazine
C21H12ClN3O (357.06688520000006)
S-Methyl-N-[3-(trifluoroMethyl)phenylsulfonyl]hoMocysteine
4-(10-bromoanthracen-9-yl)benzonitrile
C21H12BrN (357.01530520000006)
4-(4-BROMO-1H-PYRAZOL-1-YL)-N,N-DIETHYLBENZENESULFONAMIDE
C13H16BrN3O2S (357.01465360000003)
4-(4-Bromo-1H-pyrazol-1-yl)-N-butylbenzenesulfonamide
C13H16BrN3O2S (357.01465360000003)
4-(4-Bromo-1H-pyrazol-1-yl)-N-(tert-butyl)benzenesulfonamide
C13H16BrN3O2S (357.01465360000003)
1,1,2,2,3,3,4,4,4-nonafluoro-N-(2-hydroxyethyl)-N-methylbutane-1-sulphonamide
Clopidogrel hydrochloride
C16H17Cl2NO2S (357.03570020000006)
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
N-(6-acetamido-3-prop-2-enyl-1,3-benzothiazol-2-ylidene)-2-thiophenecarboxamide
2-(2,4-Dichlorophenyl)-alpha-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolane-4-ethanol
C15H17Cl2N3O3 (357.0646912000001)
9-Hydroxy-8-methoxy-6-nitro-phenanthrol[3,4-D][1,3]dioxole-5-carboxylic acid
(3R)-3-[3,5-Bis(trifluoromethyl)anilino]-2-cyano-3-sulfanylpropanamide
C12H9F6N3OS (357.03704960000005)
Droxicam
C16H11N3O5S (357.04193960000003)
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AC - Oxicams C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
(Z,4E)-4-[cyano-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylidene]hex-2-enedioic acid
3-bromo-N-(4-methyl-2-oxo-1-benzopyran-7-yl)benzamide
C17H12BrNO3 (357.00005020000003)
(2S-3S)-versiconal hemiacetal(1-)
A phenolate anion obtained by deprotonation of the 8-hydroxy group of (2S-3S)-versiconal hemiacetal. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
3-(4-Bromophenyl)acrylaldehyde 1,3-benzothiazol-2-ylhydrazone
2-[[5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-(2-pyridinyl)acetamide
C15H11N5O4S (357.05317260000004)
4-[[5-(1,3-Benzothiazol-2-yl)-2-thiophenyl]-oxomethyl]-1-piperazinecarboxaldehyde
1-[2-(4-Methoxyphenoxy)ethylthio]-[1,2,4]triazolo[3,4-b][1,3]benzothiazole
3-[(E)-(2-bromophenyl)methylideneamino]-5-phenyl-1H-imidazole-2-thione
N-[(5-bromo-2-methoxyphenyl)methyl]-2-[(1-methyl-5-tetrazolyl)thio]ethanamine
C12H16BrN5OS (357.02588660000004)
2-[[[4-(2-Chlorophenyl)-1,3-thiazol-2-yl]hydrazinylidene]methyl]benzoic acid
2,2-dichloro-N-[(2R)-3-fluoro-1-hydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamide
C12H14Cl2FNO4S (357.00045960000006)
2-(2,4-dichlorophenoxy)-N-[5-(2,2-dimethylpropyl)-1,3,4-oxadiazol-2-yl]acetamide
C15H17Cl2N3O3 (357.0646912000001)
4-Hydroxy-3-[(2-methoxyphenyl)diazenyl]naphthalene-1-sulfonate
C17H13N2O5S- (357.05451480000005)
CHLORSULFURON
C12H12ClN5O4S (357.02985020000006)
D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals
Tnp-Gln
An L-alpha-amino acid that is L-glutamine substituted at the alpha-nitrogen by a 2,4,6-trinitrophenyl group.
1,4-dihydroxymidazolam
An imidazobenzodiazepine that is midazolam which is substituted by a hydroxy group at positions 2 and 4. It is the minor metabolite of the anesthetic, midazolam.
SR 16832
C17H12ClN3O4 (357.05163020000003)
SR 16832 is a dual site covalent PPARγ inhibitor that acts at orthosteric and allosteric sites[1].
(4s,6s)-6-[(4-bromo-1h-pyrrole-2-carbonyloxy)methyl]-1,6-dimethyl-4,5-dihydropyrimidine-4-carboxylic acid
C13H16BrN3O4 (357.03241160000005)
9-hydroxy-8-methoxy-6-nitro-2h-phenanthro[3,4-d][1,3]dioxole-5-carboxylic acid
8-hydroxy-7-methoxy-3,4-methylenedioxy-10-nitro-1-phenanthrenecarboxylic acid
{"Ingredient_id": "HBIN013770","Ingredient_name": "8-hydroxy-7-methoxy-3,4-methylenedioxy-10-nitro-1-phenanthrenecarboxylic acid","Alias": "NA","Ingredient_formula": "C17H11NO8","Ingredient_Smile": "NA","Ingredient_weight": "357.27","OB_score": "NA","CAS_id": "107259-48-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7350","PubChem_id": "NA","DrugBank_id": "NA"}
aristolochicacid e
{"Ingredient_id": "HBIN016805","Ingredient_name": "aristolochicacid e","Alias": "NA","Ingredient_formula": "C17H11NO8","Ingredient_Smile": "COC1=C(C2=CC(=C3C(=CC4=C(C3=C2C=C1)OCO4)C(=O)O)[N+](=O)[O-])O","Ingredient_weight": "357.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1715","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "147113","DrugBank_id": "NA"}
(1r,4r,5s)-4-(2-bromoethyl)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one
C15H20BrNO4 (357.0575620000001)
(1s,4r,5s)-4-(2-bromoethyl)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one
C15H20BrNO4 (357.0575620000001)
3-(3-bromo-4-hydroxyphenyl)-n-[2-(cyanosulfanyl)ethyl]-2-(n-hydroxyimino)propanamide
(2e)-3-(3-bromo-4-hydroxyphenyl)-n-[2-(cyanosulfanyl)ethyl]-2-(n-hydroxyimino)propanimidic acid
6-[(4-bromo-1h-pyrrole-2-carbonyloxy)methyl]-1,6-dimethyl-4,5-dihydropyrimidine-4-carboxylic acid
C13H16BrN3O4 (357.03241160000005)
4-(2-bromoethyl)-1-[cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one
C15H20BrNO4 (357.0575620000001)